Form 8-K - Current report:
SEC Accession No. 0001493152-24-042911
Filing Date
2024-10-29
Accepted
2024-10-29 16:45:14
Documents
14
Period of Report
2024-10-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41956
  Complete submission text file 0001493152-24-042911.txt   265654

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocea-20241023.xsd EX-101.SCH 3509
3 XBRL DEFINITION FILE ocea-20241023_def.xml EX-101.DEF 29931
4 XBRL LABEL FILE ocea-20241023_lab.xml EX-101.LAB 36433
5 XBRL PRESENTATION FILE ocea-20241023_pre.xml EX-101.PRE 26954
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5601
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

EIN.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 241406356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)